Comprehensive Medical Review Notes

Anemia, Pneumonia & Pulmonary Edema

1. ANEMIA

Definition

A condition where the number of red blood cells (RBCs) or hemoglobin (Hb) concentration is lower
than normal, resulting in reduced oxygen-carrying capacity of the blood.

A. IRON DEFICIENCY ANEMIA (IDA)

Overview

• Type: Microcytic, hypochromic anemia

• Cause: Insufficient iron for hemoglobin synthesis

• Prevalence: Most common nutritional disorder globally

Epidemiology - High Risk Groups

• Infants & children (rapid growth phases)

• Pregnant women (increased iron demands)

• Women with heavy menstruation (menorrhagia)

• Elderly (chronic GI losses)

Etiology/Causes

Category Examples

Inadequate Intake Poor diet, vegetarian/vegan diet without supplements, malnutrition

Increased
Pregnancy, lactation, growth spurts in children, athletes
Demand

Chronic Blood GI bleeding (ulcer, colon cancer, hemorrhoids), menorrhagia, repeated blood
Loss donation

Malabsorption Celiac disease, post-gastrectomy, H. pylori infection, chronic diarrhea

Pathophysiology Flow

↓ Iron intake / ↑ Iron loss / Malabsorption

↓
↓ Iron stores (ferritin, hemosiderin)

↓ Hemoglobin synthesis

Microcytic, hypochromic RBCs

↓ O₂ transport → Tissue hypoxia

Clinical manifestations

Clinical Manifestations

System Manifestation Reason

General Fatigue, weakness, pallor, cold intolerance Hypoxia

Cardiac Tachycardia, palpitations Compensatory mechanism

Respiratory Dyspnea on exertion Low O₂ transport

Neurological Headache, dizziness, irritability Cerebral hypoxia

Brittle nails, koilonychia (spoon-shaped nails), dry

Skin/Hair/Nails Poor tissue oxygenation
hair

Glossitis (red, smooth tongue), angular cheilitis, Iron deficiency effect on

GI/Oral
pica (craving ice, clay, starch) mucosa & taste

Diagnostic Evaluation

Test Description IDA Findings

Hemoglobin, hematocrit, RBC ↓ Hb & Hct; Microcytic (↓ MCV), Hypochromic

CBC
indices (↓ MCHC) N: 32-36 g/dL

Serum Iron & Measures circulating iron &

↓ Serum iron, ↑ TIBC
TIBC binding capacity

Serum Ferritin Reflects iron storage ↓ Ferritin (earliest sign)

Transferrin
% of iron bound to transferrin < 15% (low)
Saturation
Test Description IDA Findings

Peripheral Smear Examines RBC morphology Small, pale RBCs

Bone Marrow
Gold standard for iron stores Absence of iron
Biopsy

Management

Treatment Action

Oral Iron Supplements (Ferrous sulfate, First-line therapy; take on empty stomach with vitamin
gluconate, fumarate) C for better absorption

IV Iron For malabsorption or intolerance to oral iron

Only if severe/symptomatic anemia (Hb < 7 g/dL with

Blood Transfusion
symptoms)

Treat Underlying Cause Stop bleeding (treat ulcers, manage menorrhagia)

Diet for IDA

• Iron-rich foods: Red meat, liver, poultry, fish, beans, lentils, tofu, spinach

• Enhance absorption: Vitamin C-rich foods (oranges, tomatoes, guava)

• Avoid inhibitors: Tea, coffee, milk (calcium), antacids → reduce iron absorption

Nursing Management

• Encourage iron-rich diet

• Identify & treat source of bleeding

• Provide safety measures (dizziness & weakness increase fall risk)

Quick Recall Icons

• Iron loss → bleeding

• Poor diet → malnutrition

• Microcytic RBCs → defective Hb

• Koilonychia → spoon nails

• Vitamin C → enhances absorption

B. PERNICIOUS ANEMIA
Definition

A megaloblastic anemia caused by Vitamin B12 (cobalamin) deficiency due to absence of intrinsic
factor (IF). IF is a glycoprotein secreted by gastric parietal cells, essential for B12 absorption in the
ileum.

Functions of Vitamin B12

Function Explanation

Acts as cofactor in folate metabolism → needed for normal DNA

DNA Synthesis
formation and cell division

RBC Formation Helps produce healthy, mature RBCs; prevents megaloblasts

Essential for myelin sheath formation around nerves → supports

Nervous System Health
normal nerve conduction

Amino Acid & Fatty Acid Involved in breakdown of homocysteine and fatty acids → supports
Metabolism energy production

Supports neurotransmitter production → affects memory,

Mood & Cognition
concentration, mood regulation

Causes/Etiology

Cause Explanation

Autoimmune Destruction of Immune system attacks gastric parietal cells → ↓ intrinsic

Parietal Cells factor production → B12 malabsorption

Antibodies block IF from binding B12 or prevent IF-B12

Anti-Intrinsic Factor Antibodies
complex from attaching to ileal receptors

Removal or chronic atrophy eliminates parietal cells → no

Gastric Atrophy/Gastrectomy
intrinsic factor

Terminal ileum (B12 absorption site) removed or inflamed →

Ileal Resection/Disease
cannot absorb B12

Genetic Predisposition Familial tendency, higher prevalence in Northern Europeans

Associated Autoimmune
Type 1 DM, Hashimoto's, Addison's, vitiligo increase risk
Disorders

Pathophysiology Flow

Autoimmune destruction of gastric parietal cells

↓

↓ Intrinsic Factor production

Vitamin B12 cannot bind with Intrinsic Factor

No absorption of B12 in terminal ileum

B12 deficiency in blood

↓ DNA synthesis in bone marrow

Megaloblast formation (large, immature RBCs)

Ineffective erythropoiesis & premature RBC death

Anemia + ↓ Myelin synthesis

Neurological complications

Clinical Manifestations

Common Anemia Symptoms

• Fatigue and easy tiredness

• Weakness

• Pallor (pale skin and mucous membranes)

• Shortness of breath (especially on exertion)

• Dizziness or lightheadedness

• Headache

• Palpitations/rapid heart rate

Specific Symptoms of Pernicious Anemia

Gastrointestinal:
 • Smooth, beefy-red sore tongue (glossitis)

• Loss of appetite, weight loss

• Nausea, diarrhea or constipation

Neurological:

• Numbness, tingling (paresthesia) in hands and feet

• Poor balance, unsteady gait, ataxia

• Weakness of extremities

• Memory problems, confusion, depression

• Dementia in severe or long-standing cases

Diagnostic Evaluations

Test Procedure Findings

Low hemoglobin/hematocrit, macrocytic

CBC with MCV Blood sample analyzed
anemia (↑ MCV) Normal = 80-100fL

Blood smear under

Peripheral Smear Oval macrocytes, hypersegmented neutrophils
microscope

Serum Vitamin Blood test for B12

Low (<200 pg/mL)
B12 Level concentration

Intrinsic Factor Blood test for antibodies

Positive (specific for pernicious anemia)
Antibody Test against IF

Parietal Cell Blood test for antibodies

Often positive, but less specific
Antibody Test against gastric parietal cells

Medical Management

Management Action/Use

Vitamin B12 Replacement Main treatment. Corrects B12 deficiency, restores RBC
(Cyanocobalamin or Hydroxocobalamin) production, improves neurological function

Initial Parenteral Therapy Rapid correction of deficiency. Daily or weekly until

(IM/Subcutaneous) levels normalize

Maintenance Therapy (Monthly IM or High- Lifelong therapy since absorption problem is

Dose Oral B12) permanent
Management Action/Use

Supports RBC production and DNA synthesis if

Folic Acid Supplementation
deficient

Helps replenish iron stores if deficient due to chronic

Iron Supplementation
anemia

Blood Transfusion Only in severe, symptomatic anemia

Monitoring CBC, B12 levels, neurologic assessment

Educate that dietary B12 alone insufficient; stress

Dietary Counseling
lifelong therapy compliance

Nursing Diagnosis

• Fatigue related to decreased oxygen-carrying capacity

• Activity intolerance related to weakness and anemia

• Risk for injury related to impaired balance, numbness, paresthesia

• Imbalanced nutrition related to impaired B12 absorption

Nursing Interventions

• Administer B12 replacement as prescribed

• Monitor CBC, hemoglobin, hematocrit, B12 levels

• Assess for neurological changes

• Promote safety measures (assist with ambulation, fall precautions)

• Encourage rest and balanced activity

• Provide dietary teaching - emphasize lifelong therapy adherence

• Offer emotional support and health education

Complications

System Complications

Neurological Peripheral neuropathy, ataxia, memory loss, confusion, dementia

Gastrointestinal Glossitis, gastric atrophy, increased risk for gastric carcinoma

Hematologic Severe anemia symptoms, heart failure (chronic severe cases)

System Complications

Immune/Systemic Impaired immune response, increased infection susceptibility

2. PNEUMONIA

Definition

An acute infection of the lung parenchyma (alveoli, interstitium, bronchioles) caused by bacteria,
viruses, fungi, or aspiration, leading to inflammation and impaired gas exchange.

Classification of Pneumonia

Type Description Common Causes

Streptococcus pneumoniae,
Community Acquired Occurs outside hospital or <48
Mycoplasma pneumoniae, H.
Pneumonia (CAP) hrs after admission
influenzae, viruses

Hospital-Acquired Develops ≥48 hrs after

Pseudomonas, MRSA, Klebsiella
Pneumonia (HAP) hospitalization

Ventilator-Associated
Occurs 48-72 hrs after intubation Multi-drug resistant organisms
Pneumonia (VAP)

Due to inhalation of
Aspiration Pneumonia Anaerobes, chemical injury
gastric/oropharyngeal contents

Opportunistic
In immunocompromised patients Pneumocystis jirovecii, CMV, fungi
Pneumonia

Pathophysiology Stages

Stage Pathologic Changes Key Features

Congestion (0-24 hrs) Alveolar edema, bacteria multiply Heavy red lungs

Red Hepatization (2-3

Exudation of RBCs, neutrophils, fibrin Lungs look like liver
days)

Gray Hepatization (4-6 Disintegration of RBCs, fibrinopurulent Grayish lung, decreased

days) exudate perfusion

Enzymatic digestion, clearance by Restoration of normal lung

Resolution (7-10 days)
macrophages function

Pathophysiology Flowchart
Pathogen Entry → Alveolar Infection

Inflammatory Response (neutrophils, macrophages, cytokines)

Alveolar Capillary Leak → Exudate Formation

Alveolar Filling with fluid + WBC + Fibrin

Impaired Gas Exchange

Risk Factors

Category How it Leads to Pneumonia

Weak or immature immune system → decreased ability

Age (infants/elderly)
to fight infections

Chronic Lung Diseases (COPD, asthma, Impaired mucociliary clearance + structural lung
bronchiectasis) damage → bacteria/viruses colonize easily

Chronic Illness (Diabetes, Heart Failure, Alters immune response & reduces host defense →
Kidney/Liver Disease) easier bacterial invasion

Damages cilia in airways → weakens clearance of

Smoking
pathogens and secretions

Depresses cough reflex and immunity → increases

Alcohol Abuse
aspiration risk

Low protein and vitamin levels → impaired antibody

Malnutrition
and cell-mediated immunity

Increased exposure to hospital-acquired pathogens

Prolonged Hospitalization
(often resistant)

Endotracheal tube bypasses natural defense → direct

Mechanical Ventilation
route for bacteria

Low T-cell and neutrophil activity → cannot effectively

Immunocompromised States
kill pathogens
Category How it Leads to Pneumonia

Allows bacterial overgrowth in oropharynx → aspiration

Poor Oral Hygiene
into lower lungs

Suppressed cough/gag reflex → aspiration of

Altered Consciousness
secretions

Clinical Manifestations

System Signs and Symptoms

General Fever, chills

Cough (productive or dry), purulent sputum, dyspnea, pleuritic chest pain, tachypnea,
Respiratory
crackles, decreased breath sounds, fatigue, malaise

Systemic Tachycardia, hypoxemia, cyanosis (severe)

Elderly Confusion, lethargy

Diagnostic Evaluations

Test How Performed Key Findings

Doctor listens to chest with Crackles, bronchial breath sounds,

Physical Exam
stethoscope, percusses lungs dullness on percussion

Complete Blood Blood sample → lab counts WBC, RBC, ↑ WBC with left shift (bacterial
Count (CBC) platelets infection)

Blood drawn aseptically from 2 sites

Blood Culture Identifies bacteria in bloodstream
before antibiotics → incubated

Sputum Culture & Patient coughs deeply to produce Shows bacteria type and guides
Gram Stain sputum → sample stained & cultured antibiotic

Patient stands/sits in front of X-ray Lobar consolidation, patchy

Chest X-ray
machine → image taken infiltrates

Clip sensor on finger/ear → measures

Pulse Oximetry Hypoxemia (< 95%)
oxygen saturation

Arterial Blood Gas Blood drawn from radial/arterial Hypoxemia, respiratory alkalosis
(ABG) puncture → analyzed early

CT Scan Patient lies in scanner → cross-sectional Detects abscesses, effusions,

Test How Performed Key Findings

lung images complications

Pharmacological Management

Category Drugs Action/Use

Amoxicillin, Azithromycin, Ceftriaxone Kill or inhibit growth of

Antibiotics (CAP); Piperacillin-Tazobactam, bacteria → treat bacterial
Meropenem, Vancomycin (HAP/VAP) pneumonia

Inhibit viral replication →

Antivirals Oseltamivir (Tamiflu), Acyclovir
effective in viral pneumonia

Destroy fungal cell

Antifungals Fluconazole, Amphotericin B membrane → treat fungal
pneumonia

Relax bronchial smooth

Bronchodilators Salbutamol (SABA), Ipratropium muscles → relieve
bronchospasm & wheezing

Reduce fever, relieve chest

Antipyretics/Analgesics Paracetamol, Ibuprofen
pain & discomfort

Maintain hydration &

IV Fluids Normal Saline, Ringer's Lactate
electrolyte balance

Nasal cannula, face mask, mechanical Improve oxygenation &

Oxygen Therapy
ventilation prevent hypoxemia

Reduce lung inflammation,

Corticosteroids Prednisone, Methylprednisolone improve oxygenation (used
selectively)

Nursing Management

Focus Interventions

Airway and Position semi-Fowler's, oxygen as ordered, encourage deep

Breathing breathing/coughing, suction PRN

Hydration Encourage oral fluids (3 L/day if not contraindicated)

Comfort Bed rest, fever management (tepid sponge, antipyretics)

Focus Interventions

Monitoring V/S, O2 sat, respiratory pattern, sputum changes

Patient Education Importance of completing antibiotics, smoking cessation, vaccination

Complications

Complication Description

Pleural Effusion Fluid accumulation in pleural space

Sepsis & Septic Shock Spread of infection to bloodstream

Lung Abscess Necrosis of lung tissue

Respiratory Failure Severe hypoxemia requiring mechanical ventilation

Prevention

• Vaccination: Pneumococcal & Influenza vaccines

• Smoking cessation

• Hand hygiene

• Infection control measures in hospitals

3. PULMONARY EDEMA

Definition

Excessive accumulation of fluid in the lung's interstitial tissue and alveoli. This fluid interferes with
gas exchange → hypoxemia and respiratory distress. It is not a disease itself, but a manifestation of
underlying cardiac or non-cardiac conditions.

Types of Pulmonary Edema

Cardiogenic Pulmonary Edema (CPE)

Cause: Increased pulmonary capillary hydrostatic pressure due to left-sided heart failure

Mechanism: The failing left ventricle cannot pump blood forward effectively → blood backs up into
pulmonary veins → increased capillary pressure → transudation of fluid into alveoli

Common Causes:

• Acute Myocardial Infarction (MI)

• Hypertension crisis
 • Valvular disease (Mitral stenosis/regurgitation, Aortic stenosis)

• Cardiomyopathy

Non-Cardiogenic Pulmonary Edema (NCPE)

Cause: Increased capillary permeability or impaired removal of fluid, not related to left heart failure

Mechanism: Alveolar-capillary membrane damage allows protein-rich fluid to leak into alveoli

Common Causes:

• Acute Respiratory Distress Syndrome (ARDS)

• Inhalation injury (toxic gases, smoke)

• Aspiration (gastric contents, drowning)

• Sepsis, pancreatitis, trauma

• Drug/toxin overdose (heroin, aspirin, chemotherapy)

• High-altitude pulmonary edema (HAPE)

Normal Balance (Starling's Forces)

• Hydrostatic pressure: pushes fluid out of capillaries

• Oncotic pressure: pulls fluid into capillaries

• Lymphatic drainage: removes excess interstitial fluid

Pathophysiology Comparison

Aspect Cardiogenic PE Non-Cardiogenic PE

Primary ↑ Hydrostatic pressure due to left ↑ Capillary permeability due to

Mechanism heart failure injury/inflammation

Failing left ventricle → blood backs up Alveolar-capillary membrane injury → leak

Cause
→ ↑ PCWP (>18 mmHg) of protein-rich fluid

Transudate (low protein, plasma

Fluid Type Exudate (protein-rich, inflammatory fluid)
ultrafiltrate)

Alveolar Alveoli filled with watery fluid → Alveoli filled with proteinaceous fluid +
Changes impaired O₂ diffusion surfactant dysfunction → alveolar collapse

Hypoxemia mainly from V/Q Hypoxemia from shunting + loss of

Gas Exchange
mismatch compliance

Typical X-ray Cardiomegaly, Kerley B lines, "bat- Bilateral infiltrates, diffuse opacities, no
Aspect Cardiogenic PE Non-Cardiogenic PE

wing" perihilar pattern, pleural cardiomegaly

effusion

Often acute, triggered by MI, Variable; rapid in ARDS, gradual in sepsis or

Onset
hypertensive crisis, valvular disease toxins

Improves with diuretics, afterload Improves only if underlying cause resolved;

Reversibility
reduction, inotropes often needs prolonged ventilation

Pathophysiology Flowcharts

Cardiogenic Edema:

Left ventricular failure

Blood backs up into left atrium & pulmonary veins

↑ Pulmonary capillary hydrostatic pressure (>18 mmHg)

Fluid pushed out into lung interstitium

Alveolar flooding → gas exchange impaired

Hypoxemia (mainly V/Q mismatch)

Non-Cardiogenic Edema:

Injury to alveolar-capillary membrane

↑ Permeability of pulmonary capillaries

Protein-rich fluid leaks into alveoli

Surfactant inactivation & alveolar collapse

↓
Decreased lung compliance (stiff lungs)

Hypoxemia (due to shunting + poor oxygen diffusion)

Clinical Manifestations

Early Symptoms:

• Dyspnea on exertion

• Orthopnea (difficulty breathing lying down)

• Paroxysmal nocturnal dyspnea

Progressive Symptoms:

• Severe shortness of breath, tachypnea

• Cough with frothy pink sputum (classic sign)

• Crackles/rales on auscultation

• Wheezing (cardiac asthma)

• Cyanosis and low SpO₂

• Tachycardia (early); Hypotension (late/severe)

• Restlessness, confusion (due to hypoxemia)

Diagnostic Evaluation

Chest X-Ray

Cardiogenic:

• Cardiomegaly (enlarged heart silhouette)

• Kerley B lines (interstitial edema)

• Perihilar "bat-wing" or butterfly pattern

• Pleural effusion possible

Non-Cardiogenic:

• Bilateral diffuse infiltrates

• No cardiomegaly

Arterial Blood Gas (ABG)

• Early: Hypoxemia + respiratory alkalosis (due to hyperventilation)

• Later/severe: Respiratory acidosis + worsening hypoxemia

B-type Natriuretic Peptide (BNP)

• Elevated in cardiogenic pulmonary edema (>100 pg/mL)

• Helps distinguish cardiac vs. non-cardiac causes

Echocardiography

• Evaluates left ventricular function (systolic/diastolic)

• Detects valvular heart disease

• Differentiates heart failure-related pulmonary edema

Pulmonary Artery Catheterization

• Measures Pulmonary Capillary Wedge Pressure (PCWP)

• >18 mmHg → Cardiogenic pulmonary edema

• <18 mmHg → Non-cardiogenic pulmonary edema

• Normal: 6-12 mmHg

Clinical Examination

• Auscultation: crackles/rales, wheezing

• Observation: frothy pink sputum, cyanosis, dyspnea

Medical Management

Emergency Care:

• Ensure airway, breathing, circulation (ABC)

• Oxygen therapy (nasal cannula, mask, or high-flow)

• CPAP or BiPAP if hypoxemia persists

• Intubation + mechanical ventilation if severe

• Positioning: Sit upright to reduce venous return

Specific Management

Treatment CPE NCPE

Furosemide/Lasix - reduce preload, Conservative fluid management - avoid

Diuretics
remove excess fluid overload while maintaining perfusion

Nitroglycerin, Nitroprusside - reduce Treat underlying cause - sepsis, trauma,

Vasodilators
afterload & preload aspiration, toxins
Treatment CPE NCPE

Decreases anxiety, preload &

Corticosteroids (selected cases) -
Morphine pulmonary congestion (use
reduce inflammation, capillary leak
cautiously)

Dobutamine, Milrinone, Dopamine - Prone positioning (ARDS) - improve

Inotropes
improve contractility oxygenation

ACE inhibitors, beta-blockers - control Supportive therapy - electrolyte

Antihypertensives
BP, reduce afterload correction, nutrition, monitoring

High Fowler's - reduces venous

Positioning Prone or Semi-Fowler's - prone in ARDS
return, improves lung expansion

Nursing Management

• Frequent assessment: monitor respiratory rate, O₂ saturation, ABGs, hemodynamic status

• Positioning: High Fowler's to improve ventilation

• Oxygen administration as prescribed

• Medication administration: diuretics, vasodilators, morphine, inotropes

• Fluid balance monitoring: strict I&O, daily weights

• Emotional support: reassure patient, reduce anxiety

• Patient education:

o Lifestyle modification (low-salt diet, fluid restriction)

o Medication compliance

o Recognition of early warning signs (sudden weight gain, worsening dyspnea, edema)

Complications

• Respiratory failure

• Severe hypoxemia → multi-organ failure

• Arrhythmias due to hypoxia/electrolyte imbalance

• Death if untreated

Prognosis

• Cardiogenic: Depends on severity of heart failure; poor if recurrent or advanced

• Non-cardiogenic: Variable; ARDS has high mortality (~30-40%)

 • Early recognition & management significantly improve outcomes

Key Learning Points for Reviewers

Differential Diagnosis Tips

1. Anemia Types: Microcytic (IDA) vs. Macrocytic (Pernicious)

2. Pneumonia Classification: Community vs. Hospital-acquired patterns

3. Pulmonary Edema: Cardiogenic (heart-related) vs. Non-cardiogenic (lung injury)

Critical Lab Values

• IDA: ↓ Ferritin (earliest sign), ↓ MCV, ↓ MCHC

• Pernicious Anemia: ↑ MCV (>100 fL), ↓ B12 (<200 pg/mL)

• Pneumonia: ↑ WBC with left shift

• Pulmonary Edema: BNP >100 pg/mL (cardiogenic), PCWP >18 mmHg

Emergency Recognition

• Severe Anemia: Hb <7 g/dL with symptoms → transfusion

• Pneumonia Complications: Sepsis, respiratory failure

• Pulmonary Edema: Frothy pink sputum = emergency

Treatment Priorities

1. IDA: Oral iron + treat underlying cause

2. Pernicious Anemia: Lifelong B12 replacement

3. Pneumonia: Appropriate antibiotics + supportive care

4. Pulmonary Edema: ABC, positioning, treat underlying cause